Snapdragon Chemistry CEO Matt Bio talks continuous manufacturing in drug development on Biotech 2050

Updated: Feb 2

Matt Bio, CEO of Snapdragon Chemistry discusses how continuous manufacturing is reshaping modern process development on the Biotech 2050 podcast. Read more or listen to the podcast at Biotech 2050 .

51 views0 comments